166 related articles for article (PubMed ID: 4725926)
21. 5,8-Disubstituted 1-aminotetralins. A class of compounds with a novel profile of central nervous system activity.
Sarges R; Tretter JR; Tenen SS; Weissman A
J Med Chem; 1973 Sep; 16(9):1003-11. PubMed ID: 4795663
[No Abstract] [Full Text] [Related]
22. Behavioural effects of some derivatives of amphetamine and LSD and their significance.
Smythies JR; Beaton J; Benington F; Morin RD
Nature; 1970 May; 226(5246):644-5. PubMed ID: 5444927
[No Abstract] [Full Text] [Related]
23. The behavioral effects of 2,5-dimethoxy-4-alkyl amphetamines.
Morin RD; Benington F; Mitchell SR; Beaton JM; Bradley RJ; Smythies JR
Experientia; 1975 Jan; 31(1):93-5. PubMed ID: 234850
[No Abstract] [Full Text] [Related]
24. Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats.
Nichols DE; Hoffman AJ; Oberlender RA; Riggs RM
J Med Chem; 1986 Feb; 29(2):302-4. PubMed ID: 3950910
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological properties of feline red nucleus.
Davis R; Vaughan PC
Int J Neuropharmacol; 1969 Sep; 8(5):475-88. PubMed ID: 4310131
[No Abstract] [Full Text] [Related]
26. [Hallucinogen caused motility disorders in rats as potential psychosis relevant animal model].
Oelssner W
Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():53-60. PubMed ID: 7157125
[No Abstract] [Full Text] [Related]
27. LSD and phenethylamine hallucinogens: new structural analogy and implications for receptor geometry.
Nichols DE; Pfister WR; Yim GK
Life Sci; 1978 Jun; 22(24):2165-70. PubMed ID: 672453
[No Abstract] [Full Text] [Related]
28. Hallucinogens and Drosophila: linking serotonin receptor activation to behavior.
Nichols CD; Ronesi J; Pratt W; Sanders-Bush E
Neuroscience; 2002; 115(3):979-84. PubMed ID: 12435434
[TBL] [Abstract][Full Text] [Related]
29. Effect of hallucinogens and psycholeptic drugs on blood pressure reflexes and behavioral reactions in nonanesthetized cats.
Balint GA
Isr J Med Sci; 1972 Apr; 8(4):556-8. PubMed ID: 5034804
[No Abstract] [Full Text] [Related]
30. Effects of lysergic acid diethylamide on simple instrumental conditioning, extinction and discrimination learning in the rat.
Rosen AJ; Buga JA
Pharmacol Biochem Behav; 1973; 1(6):619-27. PubMed ID: 4785804
[No Abstract] [Full Text] [Related]
31. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
[TBL] [Abstract][Full Text] [Related]
32. Serotonin receptor affinities of psychoactive phenalkylamine analogues.
Glennon RA; Liebowitz SM; Anderson GM
J Med Chem; 1980 Mar; 23(3):294-9. PubMed ID: 7365744
[TBL] [Abstract][Full Text] [Related]
33. LSD as an agonist of dopamine receptors in the striatum.
Pieri L; Pieri M; Haefely W
Nature; 1974 Dec; 252(5484):586-8. PubMed ID: 4431521
[No Abstract] [Full Text] [Related]
34. The behavioral pharmacology of hallucinogens.
Fantegrossi WE; Murnane KS; Reissig CJ
Biochem Pharmacol; 2008 Jan; 75(1):17-33. PubMed ID: 17977517
[TBL] [Abstract][Full Text] [Related]
35. Hallucinogens potentiate responses to serotonin and norepinephrine in the facial motor nucleus.
McCall RB; Aghajanian GK
Life Sci; 1980 Apr; 26(14):1149-56. PubMed ID: 7392793
[No Abstract] [Full Text] [Related]
36. Serotonin and behavioral inhibition.
Stein L; Wise CD
Adv Biochem Psychopharmacol; 1974; 11(0):281-91. PubMed ID: 4276861
[No Abstract] [Full Text] [Related]
37. The prevention of isoproterenol desensitization and isoproterenol reversal.
Fleisch JH; Titus E
J Pharmacol Exp Ther; 1972 Jun; 181(3):425-33. PubMed ID: 4338173
[No Abstract] [Full Text] [Related]
38. Structure-activity relationships in potentially hallucinogenic N,N-dialkyltryptamines substituted in the benzene moiety.
Kline TB; Benington F; Morin RD; Beaton JM
J Med Chem; 1982 Aug; 25(8):908-13. PubMed ID: 7120280
[TBL] [Abstract][Full Text] [Related]
39. Lysergic acid diethylamide (LSD) and tryptamine analogs as potential psychotomimetics.
Liska KJ; Jain VO; Purich ED
J Med Chem; 1968 Sep; 11(5):1105-6. PubMed ID: 5697093
[No Abstract] [Full Text] [Related]
40. Serotonin receptor binding affinities of several hallucinogenic phenylalkylamine and N,N-dimethyltryptamine analogues.
Glennon RA; Liebowitz SM; Mack EC
J Med Chem; 1978 Aug; 21(8):822-5. PubMed ID: 278843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
